Literature DB >> 27427452

Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.

Josiah D Rich1, Curt G Beckwith2, Alexandria Macmadu3, Brandon D L Marshall4, Lauren Brinkley-Rubinstein5, Joseph J Amon6, M-J Milloy7, Maximilian R F King4, Jorge Sanchez8, Lukoye Atwoli9, Frederick L Altice10.   

Abstract

The burden of HIV/AIDS and other transmissible diseases is higher in prison and jail settings than in the non-incarcerated communities that surround them. In this comprehensive review, we discuss available literature on the topic of clinical management of people infected with HIV, hepatitis B and C viruses, and tuberculosis in incarcerated settings in addition to co-occurrence of one or more of these infections. Methods such as screening practices and provision of treatment during detainment periods are reviewed to identify the effect of community-based treatment when returning inmates into the general population. Where data are available, we describe differences in the provision of medical care in the prison and jail settings of low-income and middle-income countries compared with high-income countries. Structural barriers impede the optimal delivery of clinical care for prisoners, and substance use, mental illness, and infectious disease further complicate the delivery of care. For prison health care to reach the standards of community-based health care, political will and financial investment are required from governmental, medical, and humanitarian organisations worldwide. In this review, we highlight challenges, gaps in knowledge, and priorities for future research to improve health-care in institutions for prisoners.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27427452      PMCID: PMC5504684          DOI: 10.1016/S0140-6736(16)30379-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  82 in total

1.  Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.

Authors:  Jaimie P Meyer; Javier Cepeda; Johnny Wu; Robert L Trestman; Frederick L Altice; Sandra A Springer
Journal:  JAMA Intern Med       Date:  2014-05       Impact factor: 21.873

2.  Hepatitis C and liver transplantation.

Authors:  G Tsoulfas; I Goulis; D Giakoustidis; E Akriviadis; P Agorastou; G Imvrios; V Papanikolaou
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

Review 3.  HIV testing strategies across European countries.

Authors:  S Mounier-Jack; S Nielsen; R J Coker
Journal:  HIV Med       Date:  2008-07       Impact factor: 3.180

4.  Health outcomes for HIV-infected persons released from the New York City jail system with a transitional care-coordination plan.

Authors:  Paul A Teixeira; Alison O Jordan; Nicolas Zaller; Dipal Shah; Homer Venters
Journal:  Am J Public Health       Date:  2015-02       Impact factor: 9.308

5.  Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.

Authors:  Josiah D Rich; Michelle McKenzie; Sarah Larney; John B Wong; Liem Tran; Jennifer Clarke; Amanda Noska; Manasa Reddy; Nickolas Zaller
Journal:  Lancet       Date:  2015-05-28       Impact factor: 79.321

6.  Sofosbuvir-based treatment regimens for chronic, genotype 1 hepatitis C virus infection in U.S. incarcerated populations: a cost-effectiveness analysis.

Authors:  Shan Liu; Daena Watcha; Mark Holodniy; Jeremy D Goldhaber-Fiebert
Journal:  Ann Intern Med       Date:  2014-10-21       Impact factor: 25.391

7.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Authors:  Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall
Journal:  Lancet       Date:  2010-07-16       Impact factor: 79.321

8.  Health impact of incarceration on HIV-positive African American males: a qualitative exploration.

Authors:  Lauren Brinkley-Rubinstein; William L Turner
Journal:  AIDS Patient Care STDS       Date:  2013-08       Impact factor: 5.078

9.  Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention.

Authors:  Timothy P Flanigan; Nickolas Zaller; Curt G Beckwith; Lauri B Bazerman; Aadia Rana; Adrian Gardner; David A Wohl; Frederick L Altice
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

10.  Burden of infectious diseases, substance use disorders, and mental illness among Ukrainian prisoners transitioning to the community.

Authors:  Lyuba Azbel; Jeffrey A Wickersham; Yevgeny Grishaev; Sergey Dvoryak; Frederick L Altice
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more
  38 in total

1.  Missed Opportunities for HIV Testing Among STD Clinic Patients.

Authors:  Sharleen M Traynor; Lisa Rosen-Metsch; Daniel J Feaster
Journal:  J Community Health       Date:  2018-12

2.  Glaucoma Care of Prison Inmates at an Academic Hospital.

Authors:  Levi N Kanu; Inae Jang; Daniel J Oh; Manpreet S Tiwana; Amy A Mehta; Mark S Dikopf; Thasarat S Vajaranant; Ahmad A Aref; Deepak P Edward
Journal:  JAMA Ophthalmol       Date:  2020-04-01       Impact factor: 7.389

3.  Design and implementation of a factorial randomized controlled trial of methadone maintenance therapy and an evidence-based behavioral intervention for incarcerated people living with HIV and opioid dependence in Malaysia.

Authors:  Alexander R Bazazi; Jeffrey A Wickersham; Martin P Wegman; Gabriel J Culbert; Veena Pillai; Roman Shrestha; Haider Al-Darraji; Michael M Copenhaver; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Contemp Clin Trials       Date:  2017-05-04       Impact factor: 2.226

4.  Multicenter Evaluation of the Cepheid Xpert Hepatitis C Virus Viral Load Assay.

Authors:  M P McHugh; A H B Wu; S Chevaliez; J M Pawlotsky; M Hallin; K E Templeton
Journal:  J Clin Microbiol       Date:  2017-03-08       Impact factor: 5.948

5.  Adherence to Antiretroviral Therapy Among Incarcerated Persons with HIV: Associations with Methadone and Perceived Safety.

Authors:  Gabriel J Culbert; Agung Waluyo; Melinda Wang; Tissa Aulia Putri; Alexander R Bazazi; Frederick L Altice
Journal:  AIDS Behav       Date:  2019-08

6.  Opt-out HIV and Hepatitis C Testing at the Dallas County Jail: Uptake, Prevalence, and Demographic Characteristics of Testers.

Authors:  Carolina de la Flor; Esmaeil Porsa; Ank E Nijhawan
Journal:  Public Health Rep       Date:  2017-10-18       Impact factor: 2.792

7.  Dynamic Models of Infectious Disease Transmission in Prisons and the General Population.

Authors:  Martial L Ndeffo-Mbah; Vivian S Vigliotti; Laura A Skrip; Kate Dolan; Alison P Galvani
Journal:  Epidemiol Rev       Date:  2018-06-01       Impact factor: 6.222

8.  History of Incarceration Among Women with HIV: Impact on Prognosis and Mortality.

Authors:  Mardge H Cohen; Kathleen M Weber; Nicola Lancki; Stephen J Gange; Michael Plankey; Morgan M Philbin; Joel Milam; Adaora A Admora; Mirjam-Colette Kempf; Susan Holman; Jennifer Cohen; Antonina Foster; Oluwakemi Sosanya; Charlesnika T Evans
Journal:  J Womens Health (Larchmt)       Date:  2019-05-17       Impact factor: 2.681

9.  Opt-out Testing Pilot for Sexually Transmitted Infections Among Immigrant Detainees at 2 Immigration and Customs Enforcement Health Service Corps-Staffed Detention Facilities, 2018.

Authors:  Edith Lederman; Andria Blackwell; Gina Tomkus; Misty Rios; Brent Stephen; Ada Rivera; Philip Farabaugh
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

10.  Perceptions of Health-Related Community Reentry Challenges among Incarcerated Drug Users in Azerbaijan, Kyrgyzstan, and Ukraine.

Authors:  Julia Rozanova; Olga Morozova; Lyuba Azbel; Chethan Bachireddy; Jacob M Izenberg; Tetiana Kiriazova; Sergiy Dvoryak; Frederick L Altice
Journal:  J Urban Health       Date:  2018-08       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.